Ftse Mib
32.917,87
0,77%
DAX
18.074,52
0,30%
S&P 500
5.442,10
0,19%
NASDAQ
17.716,64
0,16%
Bitcoin
65.489,69
-1,72%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Ikena Oncology Inc (IKNA) Ikena Oncology Inc (IKNA) Notizie

Ikena Oncology Inc

IKNA
1,725
-0,025 (-1,43%)
Ultimo aggiornamento: 17:26:38
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/6/202422:05EDGAR2Form 8-K - Current report
28/5/202422:42GLOBEUPDATE – Ikena Oncology Announces Strategic Update
28/5/202422:24EDGAR2Form 8-K - Current report
28/5/202422:15GLOBEIkena Oncology Announces Strategic Update
13/5/202422:45GLOBEIkena Oncology Reports First Quarter 2024 Financial Results..
13/5/202422:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/4/202414:00GLOBEIkena Oncology to Present at the Stifel 2024 Virtual..
12/3/202413:00GLOBEIkena Oncology Reports Fourth Quarter and Full Year 2023..
05/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/2/202414:00GLOBEIkena Oncology to Participate in TD Cowen 44th Annual Health..
21/2/202422:29EDGAR2Form 8-K - Current report
21/2/202422:15GLOBEIkena Oncology Appoints Caroline Germa, M.D. as Chief..
02/2/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202422:26EDGAR2Form 8-K - Current report
18/1/202422:05GLOBEIkena Oncology Outlines Key Priorities and Provides..
09/11/202313:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202313:09EDGAR2Form 8-K - Current report
09/11/202313:00GLOBEIkena Oncology Shares Initial Positive and Differentiated..
07/11/202314:00GLOBEIkena Oncology to Present at Multiple November 2023 Investor..
11/10/202323:10EDGAR2Form 8-K - Current report
25/9/202322:05EDGAR2Form DEF 14A - Other definitive proxy statements
15/9/202322:05EDGAR2Form PRE 14A - Other preliminary proxy statements
12/9/202322:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/9/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
05/9/202314:00GLOBEIkena Oncology to Participate in September 2023 Investor..
18/8/202322:02EDGAR2Form S-3 - Registration statement under Securities Act of..
10/8/202314:00GLOBEIkena Oncology Reports Second Quarter 2023 Financial Results..
10/8/202313:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202314:02EDGAR2Form 8-K - Current report
07/8/202313:00GLOBEIkena Oncology Acquires Pionyr Immunotherapeutics in..
30/6/202323:15EDGAR2Form 8-K - Current report
Apertura: 1,75 Min: 1,69 Max: 1,76
Chiusura: 1,75

La tua Cronologia

NASDAQ
IKNA
Ikena Oncology
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network